1516
Vol. 50, No. 11
Graduate School of Pharmaceutical Sciences, Kyoto University, for allowing
us to use the NMR facilities, and Dr. N. Akimoto of the Faculty of Pharma-
ceutical Sciences, Kyoto University, for MS measurements. This work was
supported in part by a Grant-in-Aid for Scientific Research (No. 11672101)
from the Japan Society for the Promotion of Science.
(1R,4R)-p-Mentha-2,8-dien-1-ol (6): Colorless oil. [a]Dꢀꢁ186.4°
(cꢀ0.97, CHCl3) (lit., ꢁ163.8°).11) 1H-NMR (CDCl3, 500 MHz) d: 1.29
(3H, s, CH3-7), 1.56 (1H, m, Ha-5), 1.66 (1H, ddd, Jꢀ12.8, 9.5, 2.8 Hz, Ha-
6), 1.74 (3H, br s, CH3-10), 1.79 (1H, ddd, Jꢀ12.8, 8.9, 2.8 Hz, Hb-6), 1.90
(1H, m, Hb-5), 2.74 (1H, m, H-4), 4.67 (1H, br s, Ha-9), 4.78 (1H, quintet,
Jꢀ1.6 Hz, Hb-9), 5.61 (1H, dd, Jꢀ10.1, 3.4 Hz, H-3), 5.70 (1H, dd, Jꢀ10.1,
2.1 Hz, H-2). 13C-NMR (CDCl3, 125 MHz) d: 21.2 (C-10), 25.0 (C-5), 28.9
(C-7), 36.1 (C-6), 42.5 (C-4), 68.6 (C-1), 110.9 (C-9), 130.8 (C-3), 134.5
(C-2), 147.2 (C-8).
References and Notes
1) Bastien J. W., “The Kiss of Death, Chagas’ Disease in the Americas,”
The University of Utah Press, Salt Lake City, 1998.
2) Cuo J.-X. (ed.), “International Collation of Traditional and Fork Medi-
cine,” Vol. 4, World Scientific Publishing, Singapore, 1997, pp. 17—
18.
3) Matsuda H., Shimoda H., Uemura T., Yoshikawa M., Bioorg. Med.
Chem. Lett., 9, 2647—2652 (1999).
4) Matsuda H., Kagerura T., Toguchida I., Ueda H., Morikawa T.,
Yoshikawa M., Life Sci., 66, 2151—2157 (2000).
5) Wada K., Ueda N., Sawada H., Amemiya N., Haga M., Natural Medi-
cines, 51, 283—285 (1997).
Oxymercuration of (1S,4R)-p-Mentha-2,8-dien-1-ol (5) To a solution
of mercury (II) acetate in water (2 ml), THF (2 ml) and then a solution of 5
(64 mg) in THF (1 ml) were added, then the mixture was stirred at room tem-
perature for 10 min. To this mixture, 3 M NaOH (2 ml), and then 0.5 M
NaBH4 in 3 M NaOH (1 ml) were added and the mixture was stirred for
5 min. The mixture was saturated with NaCl and the THF layer was sepa-
rated, dried over anhydrous MgSO4, and concentrated to dryness. The
residue was purified by column chromatography on silica gel to give
(1S,4R)-p-mentha-2-en-1,8-diol (7, 14 mg, 19.6%).
6) Kiuchi F., Nakamura N., Miyashita N., Nishizawa S., Tsuda Y., Kondo
K., Shoyakugaku Zasshi, 43, 279—287 (1989).
7) Nakajima-Shimada J., Hirota Y., Kaneda T., Aoki T., J. Protozool.
Res., 4, 10—17 (1994).
8) Kiuchi F., Itano Y., Uchiyama N., Honda G., Tsubouchi A., Nakajima-
Shimada J., Aoki T., J. Nat. Prod., 65, 509—512 (2002).
9) Taniguchi M., Kataoka T., Suzuki H., Uramoto M., Ando M., Arao K.,
Magae J., Nishimura T., Otake N., Nagai K., Biosci. Biotech.
Biochem., 59, 2064—2067 (1995).
10) Ando M., Kusaka H., Ohara H., Takase K., Yamaoka H., Yanagi Y., J.
Org. Chem., 54, 1952—1960 (1989).
11) Schenck G. O., Gollnick K., Buchwald G., Schroeter S., Ohloff G.,
Liebigs Ann. Chem., 674, 93—118 (1964).
12) The other possible diastereomer 9 was prepared from 6 (y. 33%) as de-
scribed for 7. The NMR spectra of 9 were different from those of 8.
Compound 9: colorless prisms (hexane–AcOEt), mp 110—112 °C. 1H-
NMR (CDCl3, 500 MHz) d: 1.17, 1.22 (each 3H, s, CH3-9,10), 1.29
(3H, s, CH3-7), 1.42 (1H, dt, Jꢀ13.5, 3.1 Hz, H-5), 1.65 (1H, td, Jꢀ13
2.8 Hz, H-6), 1.87 (1H, m, H-5), 1.94 (1H, m, H-6), 2.17 (1H, m, H-
4), 5.72 (1H, dt, Jꢀ10.7, 1.7 Hz, H-2), 5.75 (1H, dt, Jꢀ10.7, 1.3 Hz,
H-3). 13C-NMR (CDCl3, 125 MHz) d: 22.9 (C-5), 26.1 (C-9), 27.9 (C-
10), 28.2 (C-7), 38.2 (C-6), 46.9 (C-4), 69.5 (C-1), 72.6 (C-8), 127.8
(C-3), 136.5 (C-2).
13) Compound 8 showed positive optical rotation, although no reliable
[a]D value could be determined because of the scarcity of the com-
pound.
14) El-Feraly F. S., Benigni D. A., J. Nat. Prod., 43, 527—530 (1980).
15) Chiari E., de Oliveira A. B., Raslan D. S., Mesquita A. A. L., Tavares
K. G., Trans. Roy. Soc. Trop. Med. Hyg., 85, 372—374 (1991).
16) Fournet A., Muñoz V., Roblot F., Hocquemiller R., Cavé A., Gantier J.
C., Phytother. Res., 7, 111—115 (1993).
17) de Oliveria A. B., Saúde D. A., Perry K. S. P., Duarte D. S., Raslan D.
S., Boaventura M. A. D., Chiari E., Phytother. Res., 10, 292—295
(1996).
18) Inchaustil A., Yaluff G., Arias A. R., Torres S., Ferreria M. E.,
Nakayama H., Schinini A., Lorenzen K., Anke T., Fournet A., Phy-
tother. Res., 11, 193—197 (1997).
19) Brengio S. D., Belmonte S. A., Guerreiro E., Giordano O. S.,
Pietrobon E. O., Sosa M. A., J. Parasitol., 86, 407—412 (2000).
20) Fairlamb A. H., Cerami A., Annu. Rev. Microbiol., 46, 695—729
(1992).
21) Schirmer R. H., Müller J. G., Krauth-Siegel R. L., Angew. Chem. Int.
Ed. Engl., 34, 141—154 (1995).
(1S,4R)-p-Mentha-2-en-1,8-diol (7): Colorless oil. [a]Dꢀꢂ28.0° (cꢀ1.4,
CHCl3). 1H-NMR (CDCl3, 500 MHz) d: 1.19, 1.26 (each 3H, s, CH3-9, 10),
1.29 (3H, s, CH3-7), 1.53 (2H, m), 1.75 (1H, m), 1.88 (1H, m), 2.06 (1H, m,
H-4), 5.77 (1H, dt, Jꢀ10.1, 1.8 Hz, H-3), 5.88 (1H, dt, Jꢀ10.1, 1.8 Hz, H-
2). 13C-NMR (CDCl3, 125 MHz) d: 20.4 (C-5), 26.3 (C-9), 28.1 (C-10), 29.6
(C-7), 37.0 (C-6), 47.0 (C-4), 66.9 (C-1), 72.6 (C-8), 130.0 (C-3), 134.9 (C-
2).
Hydrolysis and Reduction of Compound 3 A mixture of compound 3
(0.5 mg) in MeOH (0.1 ml) and 10% NaOH (0.1 ml) was stirred at room
temperature for 1 h. The mixture was neutralized and applied to a silica gel
column, which was eluted with AcOEt to give an alcohol. The alcohol was
dissolved in ether (1 ml) and stirred with PPh3 (1.4 mg) at room temperature
for 40 min. The mixture was concentrated to dryness and the residue was pu-
rified by silica gel column chromatography with hexane : AcOEt (5 : 4) to
give the diol 8, whose 1H- and 13C-NMR spectra were identical with those of
(1S,4R)-p-mentha-2-en-1,8-diol (7).
GC-MS Analysis with Chiral Capillary Column GC-MS analysis was
performed on a Hitachi G-7000M/M-9000 system equipped with a Cy-
clodex-B chiral capillary column (0.25 mmꢃ30 m, J & W). GC conditions:
column temperature, starting at 40 °C, 10°/min to 100 °C, 5°/min to 130 °C,
3°/min to 160 °C, 20°/min to 220 °C; injector temperature, 100 °C; carrier
gas, He; flow rate, 1 ml/min. Retention time: the diol (8) derived from com-
pound 3, 20.68 min; compound 7, 20.92 min. MS conditions: mode, EI; ion-
ization voltage: 15 eV. The MS patterns of 7 and 8 were identical; m/z (%):
152 (MꢁꢂH2O, 1), 135 (13), 110 (33), 96 (25), 95 (98), 92 (18), 80 (100).
Trypanocidal Assay Trypanocidal assay was performed as described
previously.8) EtOH was used as a negative control. Ketoconazole and gentian
violet were used as positive controls. The MLCs of ketoconazole and gen-
tian violet under this assay condition were 50 mM and 6.3 mM, respectively.
HeLa Infection Assay The HeLa cell infection assay was performed as
described previously.7) A round coverslip was placed in each well of a 24-
well plate. Exponentially growing HeLa cells (5ꢃ103 cells/ml/well) were
added to each well, followed by incubation at 37 °C for 2 d in 5% CO2 in air.
The cells were then infected with T. cruzi trypomastigotes (1ꢂ2ꢃ104 para-
sites/well). A compound to be tested was dissolved in ethanol (10 ml) and
added immediately after infection. HeLa cells attached to the coverslip were
fixed and stained with Diff-Quik (Kokusai Shiyaku) at day 4 after infection.
The coverslip was then transferred upside down to a slide glass, and the cells
were finally embedded in HSR solution (Kokusai Shiyaku) for observation
under a microscope. The percentage of infected host cells, i.e. those contain-
ing more than one amastigote, and the mean number of amastigotes per in-
fected cell were determined by analyzing more than 200 host cells distrib-
uted in randomly chosen microscopic fields. Allopurinol was used as a posi-
tive control.
22) Sepúlveda-Boza S., Cassels B. K., Planta Med., 62, 98—105 (1996).
23) D’Silva C., Daunes S., Expert Opin. Investig. Drugs, 11, 217—231
(2002).
Acknowlegements The authors thank Professor K. Tomioka of the